Parameter
| Biomarker | NT-proBNP | Full name | N-terminal B-type natriuretic peptide precursor | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognostic assessment, complication monitoring |
| Disease | pneumonia | Disease Subtypes | / | ||
| Organ | Lung | Test Sample / Technology Platform | Serum (immunoassay technology) | ||
| Pathobiological Mechanisms | B-type natriuretic peptide has no active precursor peptide, and when pneumonia causes hypoxia, lung inflammation and compression, or heart failure, the increase in ventricular load stimulates its release, which is positively correlated with ventricular pressure and volume load | ||||
| Clinical Availability Status | Clinical application: reflects the state of cardiac function and indirectly suggests the effect of pneumonia on the circulatory system | ||||
| Notes and Dynamics | The higher the level of admission, the longer the hospital stay and the higher the mortality rate; It can be monitored for cardiac insufficiency | ||||